7595738

Source:http://linkedlifedata.com/resource/pubmed/id/7595738

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0021734, umls-concept:C0025202, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0543467, umls-concept:C1522673, umls-concept:C1707391
pubmed:issue	11
pubmed:dateCreated	1995-12-15
pubmed:abstractText	We conducted a randomized prospective trial in selected patients with fully resected high-risk stage I and II malignant melanoma.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-15083, http://linkedlifedata.com/resource/pubmed/grant/CA-25224, http://linkedlifedata.com/resource/pubmed/grant/CA-35269
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AhmannD LDL, pubmed-author:CreaganE TET, pubmed-author:DaltonR JRJ, pubmed-author:JungS HSH, pubmed-author:KuglerJJ, pubmed-author:LangdonR MRMJr, pubmed-author:MortonR FRF, pubmed-author:RodrigueL JLJ
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2776-83
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:7595738-Adult, pubmed-meshheading:7595738-Aged, pubmed-meshheading:7595738-Aged, 80 and over, pubmed-meshheading:7595738-Canada, pubmed-meshheading:7595738-Chi-Square Distribution, pubmed-meshheading:7595738-Combined Modality Therapy, pubmed-meshheading:7595738-Disease-Free Survival, pubmed-meshheading:7595738-Female, pubmed-meshheading:7595738-Humans, pubmed-meshheading:7595738-Interferon-alpha, pubmed-meshheading:7595738-Male, pubmed-meshheading:7595738-Melanoma, pubmed-meshheading:7595738-Middle Aged, pubmed-meshheading:7595738-Neoplasm Recurrence, Local, pubmed-meshheading:7595738-Prospective Studies, pubmed-meshheading:7595738-Recombinant Proteins, pubmed-meshheading:7595738-Skin Neoplasms, pubmed-meshheading:7595738-Survival Rate, pubmed-meshheading:7595738-United States
pubmed:year	1995
pubmed:articleTitle	Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.
pubmed:affiliation	Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Multicenter Study